Omnicell Inc. (OMCL)
Omnicell, Inc. (OMCL) Shareholder/Analyst Call Prepared Remarks Transcript
Omnicell, Inc. (OMCL) Shareholder/Analyst Call Prepared Remarks Transcript
Omnicell, Inc. (OMCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Omnicell, Inc. (OMCL) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Here's Why Omnicell (OMCL) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Omnicell (OMCL) is a Great Momentum Stock: Should You Buy?
Does Omnicell (OMCL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Surging Earnings Estimates Signal Upside for Omnicell (OMCL) Stock
Omnicell (OMCL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 41.19% Upside in Omnicell (OMCL): Can the Stock Really Move This High?
The mean of analysts' price targets for Omnicell (OMCL) points to a 41.2% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Omnicell Q1 Earnings & Revenues Top, Stock Up, Gross Margin Rises
OMCL posts Q1 earnings and revenue beat with surging margins and strong demand, sending shares sharply higher after results.
Here's Why Omnicell (OMCL) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
OMCL vs. HIMS: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical Info Systems sector might want to consider either Omnicell (OMCL) or Hims & Hers Health, Inc. (HIMS). But which of these two companies is the best option for those looking for undervalued stocks?
Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript
Omnicell, Inc. (OMCL) Q1 2026 Earnings Call Transcript
Omnicell (OMCL) Q1 Earnings and Revenues Surpass Estimates
Omnicell (OMCL) came out with quarterly earnings of $0.55 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.26 per share a year ago.
Should You Continue to Hold OMCL Stock in Your Portfolio?
Omnicell's autonomous pharmacy push and SaaS growth show promise, but rising costs and weak hospital spending cloud its near-term outlook.
